Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis — Stella

Home/Systemic Sclerosis/Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis

View on ClinicalTrials.gov

Recruiting

Back to Systemic Sclerosis trials

Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(3 sites)

United States

Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania

Key details

Phase

Safety & dosing

Sponsor

Paul Szabolcs

Enrollment target

~8 participants

Started

July 2018

Primary completion

August 2026

Age range

8 Years – 60 Years

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.